Global Obesity and Overweight Treatment Market Size, Status and Forecast 2022


Report ID : RNR-188431 Category : Medical Devices Published Date : 14-Sep-17
Publisher : QYResearch Pages : 131 Format : PDF
This report studies the Obesity and Overweight Treatment market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Obesity and Overweight Treatment market by product and Application/end industries.

The global Obesity and Overweight Treatment market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

United States will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Obesity and Overweight Treatment.

EU also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. 

The major players in global market include 
VIVUS, Inc.
Arena Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
Allergan Plc
Medtronic
Ethicon 
Cousin Biotech, 
EnteroMedics, Inc.
USGI Medical, Inc.


Geographically, this report split global into several key Regions, with, revenue (million USD), market share and growth rate of Obesity and Overweight Treatment for these regions, from 2012 to 2022 (forecast)
United States
EU
Japan
China
India 
Southeast Asia

On the basis of product, the Obesity and Overweight Treatment market is primarily split into 
Gastric Electrical Stimulation
Ingestible Capsules 
Smart Pill
Electronic Drug Delivery Systems

Table of Contents

1 Industry Overview
1.1 Obesity and Overweight Treatment Market Overview
1.1.1 Obesity and Overweight Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Obesity and Overweight Treatment Market Size and Analysis by Regions (2012-2017)
1.2.1 United States Obesity and Overweight Treatment Market Status and Outlook
1.2.2 EU Obesity and Overweight Treatment Market Status and Outlook
1.2.3 Japan Obesity and Overweight Treatment Market Status and Outlook
1.2.4 China Obesity and Overweight Treatment Market Status and Outlook
1.2.5 India Obesity and Overweight Treatment Market Status and Outlook
1.2.6 Southeast Asia Obesity and Overweight Treatment Market Status and Outlook
1.3 Classification of Obesity and Overweight Treatment by Product
1.3.1 Global Obesity and Overweight Treatment Revenue (Million USD) and Growth (%) Comparison by Product (2012-2022)
1.3.2 Global Obesity and Overweight Treatment Revenue (Million USD) Market Share (%) by Product in 2016
1.3.3 Gastric Electrical Stimulation
1.3.4 Ingestible Capsules
1.3.5 Smart Pill
1.3.4 Electronic Drug Delivery Systems
1.4 Obesity and Overweight Treatment Market by End Users/Application
1.5 Population of Obesity and Overweight by Region
2 Global Obesity and Overweight Treatment Competition Analysis by Players
2.1 Global Obesity and Overweight Treatment Market Size (Million USD) by Players (2012-2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles and Key Data
3.1 VIVUS, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 VIVUS, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.1.5 Recent Developments
3.2 Arena Pharmaceuticals, Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Arena Pharmaceuticals, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 F. Hoffmann-La Roche Ltd. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.3.5 Recent Developments
3.4 Novo Nordisk A/S
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Novo Nordisk A/S Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.4.5 Recent Developments
3.5 Allergan Plc
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Allergan Plc Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.5.5 Recent Developments
3.6 Medtronic
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Medtronic Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.6.5 Recent Developments
3.7 Ethicon
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Ethicon Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.7.5 Recent Developments
3.8 Cousin Biotech,
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cousin Biotech, Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.8.5 Recent Developments
3.9 EnteroMedics, Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 EnteroMedics, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.9.5 Recent Developments
3.10 USGI Medical, Inc.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 USGI Medical, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.10.5 Recent Developments
4 Global Obesity and Overweight Treatment Market Size by Product and Application (2012-2017)
4.1 Global Obesity and Overweight Treatment Market Size by Product (2012-2017)
4.2 Global Obesity and Overweight Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Obesity and Overweight Treatment in Future
4.4 Top Consumer / End Users of Obesity and Overweight Treatment
5 United States Obesity and Overweight Treatment Development Status and Outlook
5.1 United States Obesity and Overweight Treatment Market Size (2012-2017)
5.2 United States Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
5.3 United States Obesity and Overweight Treatment Market Size by Application (2012-2017)
6 EU Obesity and Overweight Treatment Development Status and Outlook
6.1 EU Obesity and Overweight Treatment Market Size (2012-2017)
6.2 EU Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
6.3 EU Obesity and Overweight Treatment Market Size by Application (2012-2017)
7 Japan Obesity and Overweight Treatment Development Status and Outlook
7.1 Japan Obesity and Overweight Treatment Market Size (2012-2017)
7.2 Japan Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
7.3 Japan Obesity and Overweight Treatment Market Size by Application (2012-2017)
8 China Obesity and Overweight Treatment Development Status and Outlook
8.1 China Obesity and Overweight Treatment Market Size and Forecast (2012-2017)
8.2 China Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
8.3 China Obesity and Overweight Treatment Market Size by Application (2012-2017)
9 India Obesity and Overweight Treatment Development Status and Outlook
9.1 India Obesity and Overweight Treatment Market Size and Forecast (2012-2017)
9.2 India Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
9.3 India Obesity and Overweight Treatment Market Size by Application (2012-2017)
10 Southeast Asia Obesity and Overweight Treatment Development Status and Outlook
10.1 Southeast Asia Obesity and Overweight Treatment Market Size and Forecast (2012-2017)
10.2 Southeast Asia Obesity and Overweight Treatment Market Size and Market Share by Players (2012-2017)
10.3 Southeast Asia Obesity and Overweight Treatment Market Size by Application (2012-2017)
11 Market Forecast by Regions, Product and Application (2017-2022)
11.1 Global Obesity and Overweight Treatment Market Size (Million USD) by Regions (2017-2022)
11.1.1 United States Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.1.2 EU Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.1.3 China Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.1.4 Japan Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.1.5 Southeast Asia Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.1.6 India Obesity and Overweight Treatment Revenue and Growth Rate (2017-2022)
11.2 Global Obesity and Overweight Treatment Market Size by Application (2017-2022)
11.3 Global Obesity and Overweight Treatment Market Size by Product (2017-2022)
12 Obesity and Overweight Treatment Market Dynamics
12.1 Obesity and Overweight Treatment Market Opportunities
12.2 Obesity and Overweight Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Obesity and Overweight Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Obesity and Overweight Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding /Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer
15.4 Author List